160 related articles for article (PubMed ID: 37796299)
1. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
Deng H; Ge H; Dubey C; Losmanova T; Medová M; Konstantinidou G; Mutlu SM; Birrer FE; Brodie TM; Stroka D; Wang W; Peng RW; Dorn P; Marti TM
Cancer Immunol Immunother; 2023 Dec; 72(12):4457-4470. PubMed ID: 37796299
[TBL] [Abstract][Full Text] [Related]
2. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.
Sutherland KD; Song JY; Kwon MC; Proost N; Zevenhoven J; Berns A
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4952-7. PubMed ID: 24586047
[TBL] [Abstract][Full Text] [Related]
3. Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.
Simmons BH; Lee JH; Lalwani K; Giddabasappa A; Snider BA; Wong A; Lappin PB; Eswaraka J; Kan JL; Christensen JG; Shojaei F
Cancer Chemother Pharmacol; 2012 Aug; 70(2):213-20. PubMed ID: 22684718
[TBL] [Abstract][Full Text] [Related]
4. Early detection of pre-malignant lesions in a KRAS
Rakhit CP; Trigg RM; Le Quesne J; Kelly M; Shaw JA; Pritchard C; Martins LM
Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30760495
[TBL] [Abstract][Full Text] [Related]
5. The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
Lee JW; Zhang Y; Eoh KJ; Sharma R; Sanmamed MF; Wu J; Choi J; Park HS; Iwasaki A; Kaftan E; Chen L; Papadimitrakopoulou V; Herbst RS; Koo JS
J Thorac Oncol; 2019 Jun; 14(6):1046-1060. PubMed ID: 30771521
[TBL] [Abstract][Full Text] [Related]
6. Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS-G12D mutation and P53 knockout.
Zhang M; Jiang N; Cui R; Du S; Ou H; Chen T; Ge R; Ma D; Zhang J
J Cell Mol Med; 2019 Oct; 23(10):6978-6988. PubMed ID: 31410985
[TBL] [Abstract][Full Text] [Related]
7. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
8. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
[TBL] [Abstract][Full Text] [Related]
9. AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
Tien JC; Chugh S; Goodrum AE; Cheng Y; Mannan R; Zhang Y; Wang L; Dommeti VL; Wang X; Xu A; Hon J; Kenum C; Su F; Wang R; Cao X; Shankar S; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33972443
[TBL] [Abstract][Full Text] [Related]
10. Vaginal Squamous Cell Carcinoma Develops in Mice with Conditional Arid1a Loss and Gain of Oncogenic Kras Driven by Progesterone Receptor Cre.
Wang X; Praça MSL; Wendel JRH; Emerson RE; DeMayo FJ; Lydon JP; Hawkins SM
Am J Pathol; 2021 Jul; 191(7):1281-1291. PubMed ID: 33882289
[TBL] [Abstract][Full Text] [Related]
11. Practical use of advanced mouse models for lung cancer.
Safari R; Meuwissen R
Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
[TBL] [Abstract][Full Text] [Related]
13. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma.
Hammoud Z; Tan B; Badve S; Bigsby RM
Endocr Relat Cancer; 2008 Jun; 15(2):475-83. PubMed ID: 18509000
[TBL] [Abstract][Full Text] [Related]
14. Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles.
Talekar M; Trivedi M; Shah P; Ouyang Q; Oka A; Gandham S; Amiji MM
Mol Ther; 2016 Apr; 24(4):759-69. PubMed ID: 26686386
[TBL] [Abstract][Full Text] [Related]
15. AAV vector distribution in the mouse respiratory tract following four different methods of administration.
Santry LA; Ingrao JC; Yu DL; de Jong JG; van Lieshout LP; Wood GA; Wootton SK
BMC Biotechnol; 2017 May; 17(1):43. PubMed ID: 28506256
[TBL] [Abstract][Full Text] [Related]
16. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
Kasinski AL; Slack FJ
Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Mutant
Zhou X; Padanad MS; Evers BM; Smith B; Novaresi N; Suresh S; Richardson JA; Stein E; Zhu J; Hammer RE; O'Donnell KA
Mol Cancer Res; 2019 Feb; 17(2):594-603. PubMed ID: 30409919
[TBL] [Abstract][Full Text] [Related]
18. Versatile and enhanced tumour modelling in mice via somatic cell transduction.
Rodriguez E; Mannion L; D'Santos P; Griffiths M; Arends MJ; Brindle KM; Lyons SK
J Pathol; 2014 Mar; 232(4):449-57. PubMed ID: 24307564
[TBL] [Abstract][Full Text] [Related]
19. Methods to generate genetically engineered mouse models of soft tissue sarcoma.
Dodd RD; Añó L; Blum JM; Li Z; Van Mater D; Kirsch DG
Methods Mol Biol; 2015; 1267():283-95. PubMed ID: 25636474
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent.
Badea CT; Athreya KK; Espinosa G; Clark D; Ghafoori AP; Li Y; Kirsch DG; Johnson GA; Annapragada A; Ghaghada KB
PLoS One; 2012; 7(4):e34496. PubMed ID: 22485175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
